Stonebridge Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.4M | Buy |
196,588
+7,712
| +4% | +$622K | 0.98% | 32 |
|
|
2026
Q1 | $16.4M | Buy |
188,876
+3,407
| +2% | +$326K | 1.15% | 28 |
|
|
2025
Q4 | $17.8M | Buy |
185,469
+2,745
| +2% | +$267K | 1.23% | 26 |
|
|
2025
Q3 | $17.4M | Buy |
182,724
+639
| +0.4% | +$58.7K | 1.24% | 23 |
|
|
2025
Q2 | $15.9M | Sell |
182,085
-542
| -0.3% | -$46K | 1.21% | 24 |
|
|
2025
Q1 | $16.4M | Buy |
182,627
+1,026
| +0.6% | +$91.8K | 1.34% | 25 |
|
|
2024
Q4 | $14.5M | Sell |
181,601
-1,123
| -0.6% | -$97.2K | 1.17% | 30 |
|
|
2024
Q3 | $16.5M | Buy |
182,724
+4,497
| +3% | +$378K | 1.34% | 23 |
|
|
2024
Q2 | $14M | Buy |
178,227
+7,942
| +5% | +$651K | 1.23% | 25 |
|
|
2024
Q1 | $14.8M | Buy |
170,285
+9,108
| +6% | +$777K | 1.33% | 25 |
|
|
2023
Q4 | $13.3M | Buy |
161,177
+8,336
| +5% | +$635K | 1.33% | 20 |
|
|
2023
Q3 | $12M | Buy |
152,841
+31,281
| +26% | +$2.62M | 1.32% | 25 |
|
|
2023
Q2 | $10.7M | Buy |
121,560
+6,053
| +5% | +$521K | 1.14% | 32 |
|
|
2023
Q1 | $9.31M | Buy |
115,507
+1,373
| +1% | +$112K | 1.06% | 33 |
|
|
2022
Q4 | $8.87M | Buy |
114,134
+9,362
| +9% | +$759K | 1.05% | 37 |
|
|
2022
Q3 | $8.46M | Buy |
104,772
+4,242
| +4% | +$381K | 1.09% | 33 |
|
|
2022
Q2 | $9.02M | Buy |
100,530
+4,856
| +5% | +$492K | 1.09% | 36 |
|
|
2022
Q1 | $10.6M | Buy |
95,674
+8,678
| +10% | +$917K | 1.15% | 31 |
|
|
2021
Q4 | $9M | Buy |
86,996
+4,359
| +5% | +$505K | 0.99% | 40 |
|
|
2021
Q3 | $10.4M | Buy |
82,637
+168
| +0.2% | +$21.7K | 1.26% | 26 |
|
|
2021
Q2 | $10.2M | Buy |
82,469
+1,557
| +2% | +$195K | 1.24% | 28 |
|
|
2021
Q1 | $9.56M | Buy |
80,912
+1,275
| +2% | +$149K | 1.27% | 26 |
|
|
2020
Q4 | $9.33M | Buy |
79,637
+2,341
| +3% | +$258K | 1.41% | 20 |
|
|
2020
Q3 | $8.03M | Buy |
77,296
+878
| +1% | +$88.2K | 1.44% | 24 |
|
|
2020
Q2 | $7.01M | Buy |
76,418
+708
| +0.9% | +$67.9K | 1.3% | 25 |
|
|
2020
Q1 | $6.83M | Buy |
75,710
+6,561
| +9% | +$698K | 1.44% | 18 |
|
|
2019
Q4 | $7.84M | Sell |
69,149
-2,688
| -4% | -$295K | 1.28% | 23 |
|
|
2019
Q3 | $7.8M | Sell |
71,837
-3,516
| -5% | -$367K | 1.35% | 21 |
|
|
2019
Q2 | $7.34M | Buy |
75,353
+10
| +0% | +$913 | 1.3% | 20 |
|
|
2019
Q1 | $6.86M | Buy |
75,343
+7,319
| +11% | +$655K | 1.28% | 27 |
|
|
2018
Q4 | $6.19M | Buy |
68,024
+1,102
| +2% | +$103K | 1.44% | 23 |
|
|
2018
Q3 | $6.58M | Sell |
66,922
-2,726
| -4% | -$252K | 1.32% | 25 |
|
|
2018
Q2 | $5.96M | Buy |
69,648
+1,410
| +2% | +$118K | 1.3% | 25 |
|
|
2018
Q1 | $5.47M | Sell |
68,238
-688
| -1% | -$56.7K | 1.26% | 27 |
|
|
2017
Q4 | $5.57M | Buy |
68,926
+60,882
| +757% | +$4.88M | 1.27% | 23 |
|
|
2017
Q3 | $625K | Buy |
8,044
+650
| +9% | +$54K | 0.15% | 108 |
|
|
2017
Q2 | $656K | Sell |
7,394
-1,108
| -13% | -$93.4K | 0.17% | 102 |
|
|
2017
Q1 | $685K | Buy |
8,502
+68
| +0.8% | +$5.31K | 0.19% | 105 |
|
|
2016
Q4 | $601K | Sell |
8,434
-40
| -0.5% | -$3.14K | 0.18% | 104 |
|
|
2016
Q3 | $732K | Sell |
8,474
-600
| -7% | -$52.3K | 0.23% | 99 |
|
|
2016
Q2 | $787K | Sell |
9,074
-836
| -8% | -$67.6K | 0.27% | 94 |
|
|
2016
Q1 | $743K | Buy |
9,910
+140
| +1% | +$10.5K | 0.26% | 96 |
|
|
2015
Q4 | $751K | Buy |
9,770
+1,772
| +22% | +$133K | 0.27% | 93 |
|
|
2015
Q3 | $536K | Sell |
7,998
-550
| -6% | -$40.5K | 0.22% | 104 |
|
|
2015
Q2 | $634K | Sell |
8,548
-89
| -1% | -$6.8K | 0.24% | 95 |
|
|
2015
Q1 | $674K | Sell |
8,637
-1,637
| -16% | -$124K | 0.26% | 95 |
|
|
2014
Q4 | $742K | Sell |
10,274
-75
| -0.7% | -$5.21K | 0.3% | 85 |
|
|
2014
Q3 | $641K | Buy |
10,349
+185
| +2% | +$11.8K | 0.28% | 89 |
|
|
2014
Q2 | $648K | Buy |
10,164
+5
| +0% | +$304 | 0.29% | 88 |
|
|
2014
Q1 | $625K | Sell |
10,159
-395
| -4% | -$23K | 0.31% | 88 |
|
|
2013
Q4 | $606K | Buy |
+10,554
| New | +$598K | 0.31% | 88 |
|
Other funds holding MDT
Stonebridge Capital Advisors's MDT Position: Q2 2026 in Review
Stonebridge Capital Advisors increased its Medtronic (MDT) stake by 4.1% in Q2 2026, buying an estimated $622K and bringing the position to 196,588 shares worth $15.4M. The position accounts for 0.98% of the portfolio, ranked #32.
Stonebridge Capital Advisors first reported a position in MDT in Q4 2013 and has held it in 51 quarters since. The position peaked at $17.8M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Stonebridge Capital Advisors held 196,588 shares of Medtronic worth $15.4M as of Q2 2026.
- Stonebridge Capital Advisors bought 7,712 Medtronic shares in Q2 2026, an estimated $622K.
- Medtronic made up 0.98% of Stonebridge Capital Advisors's portfolio in Q2 2026, its #32 holding.
- Stonebridge Capital Advisors first reported a position in Medtronic in Q4 2013 and has held it in 51 quarters since.
- Stonebridge Capital Advisors's Medtronic position peaked at $17.8M in Q4 2025.
- 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Stonebridge Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.